Pivotal trial endpoints and prices of cancer drugs in the US and Europe.

Kerstin Noëlle Vokinger,Paola Daniore,Thomas J. Hwang,Chang Won Lee,Aaron S. Kesselheim

Pivotal trial endpoints and prices of cancer drugs in the US and Europe.

2020

Kerstin Noëlle Vokinger
Paola Daniore
Thomas J. Hwang
Chang Won Lee
Aaron S. Kesselheim

2077Background: A key clinical outcome for new cancer drugs is improvement in overall survival (OS), defined as time from the date of randomization to the death from any cause. However, many cancer...

Keywords:

Physical therapy
Intensive care medicine
cancer drugs
Medicine
Oncology
Cancer
overall survival
Internal medicine
Randomization

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations